What is Guardant Health's D&A?

Guardant Health (GH) reported D&A of $9.44M in Q1 2026.

How has Guardant Health's D&A changed year-over-year?

Guardant Health's D&A decreased by 7.8% year-over-year, from $10.24M to $9.44M.

What is the long-term trend for Guardant Health's D&A?

Over 4 years (2021 to 2025), Guardant Health's D&A has grown at a 15.6% compound annual growth rate (CAGR), from $22.27M to $39.74M.

Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.

Guardant Health GH D&A

D&A at other companies

Myriad GeneticsMYGN

$12.5M-13.2%

NeoGenomicsNEO

$8.58M-6.2%

IlluminaILMN

$51M-1.9%

VeracyteVCYT

$5.43M+1.3%

Biodesix, Inc.BDSX

$1.4M-3.1%

Adaptive BiotechnologiesADPT

$3.42M-20.7%

Other financials

Income statement

See full

Revenue$301.7M+48.3%

Gross profit$196.7M+52.8%

Operating income-$121.4M-9.3%

Net income-$112.1M-17.8%

EPS (diluted)-$0.85-10.4%

Balance sheet

See full

Cash & equivalents$1.1B+37.0%

Total debt$1.7B+30.5%

Total equity-$181.1M+27.8%

Total assets$1.9B+42.5%

Cash flow

See full

Operating cash flow-$65.6M-4.7%

CapEx$5.6M+25.1%

Free cash flow-$71.2M-6.0%

Valuation

See full

Market cap$19.04B+255%

Enterprise value$19.65B+229%

P/S17.6×+11.2×

Profitability

See full

Gross margin64.9%+3.6pp

Operating margin-41.4%-9.4pp

Net margin-40.1%-8.1pp

FCF margin-22%-6.7pp

Returns & leverage

See full

Return on equity-438.1%-1,655pp

Debt / equity3×—

Current ratio4.7×+0.6×

Where this comes from

Reported directly by Guardant Health in its filing.

Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.

The official record: Guardant Health’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Guardant Health's d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Guardant Health's D&A?: Guardant Health (GH) reported D&A of $9.44M in Q1 2026.
How has Guardant Health's D&A changed year-over-year?: Guardant Health's D&A decreased by 7.8% year-over-year, from $10.24M to $9.44M.
What is the long-term trend for Guardant Health's D&A?: Over 4 years (2021 to 2025), Guardant Health's D&A has grown at a 15.6% compound annual growth rate (CAGR), from $22.27M to $39.74M.
What does D&A mean?: Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.